Re-evaluation of the therapy of severe pneumonia caused by Streptococcus pneumoniae

Infectious Disease Clinics of North America

Volumn 18, Issue 4, 2004, Pages 963-974

  Plouffe Jr , Joseph F ^a,b   Martin, Daniel R ^a  

^a THE OHIO STATE UNIVERSITY COLLEGE OF MEDICINE   (United States)

^b FL 34243 ^*  (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBIOTIC AGENT; BETA LACTAM; CEPHALOSPORIN; CIPROFLOXACIN; ENZYME INHIBITOR; ERYTHROMYCIN; MACROLIDE; PENICILLIN G; QUINOLINE DERIVED ANTIINFECTIVE AGENT;

ANTIBIOTIC SENSITIVITY; CLINICAL TRIAL; COMMUNITY ACQUIRED PNEUMONIA; DIAGNOSTIC PROCEDURE; DRUG DELIVERY SYSTEM; HEALTH SURVEY; HOSPITALIZATION; HUMAN; IMMUNE DEFICIENCY; INFECTION SENSITIVITY; MORTALITY; MULTIVARIATE ANALYSIS; PATHOPHYSIOLOGY; PNEUMONIA; REVIEW; STREPTOCOCCUS PNEUMONIAE; TREATMENT OUTCOME;

ANTI-BACTERIAL AGENTS; BACTEREMIA; CEPHALOSPORINS; COMMUNITY-ACQUIRED INFECTIONS; DISEASE SUSCEPTIBILITY; DRUG RESISTANCE, MULTIPLE, BACTERIAL; DRUG THERAPY, COMBINATION; HUMANS; MACROLIDES; PNEUMONIA, PNEUMOCOCCAL;

EID: 8844236292     PISSN: 08915520     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.idc.2004.07.010     Document Type: Review

References (73)

1. R. Austrian, and J. Gold Pneumococcal bacteremia with special reference to bacteremic pneumococcal pneumonia Arch Intern Med 60 1964 759 776
2. T.J. Marrie Bacteraemic pneumococcal pneumonia: a continuously evolving disease J Infect 24 1992 247 255
3. S. Ewig, and A. Torres Severe community-acquired pneumococcal pneumonia - what might be done better Intensive Care Med 25 1999 143 145
4. J.D. Heffelfinger, S.F. Dowell, and J.H. Jorgensen Management of community- acquired pneumonia in the era pneumococcal resistance: a report from the drug-resistant Streptococcus pneumoniae therapeutic working group Arch Intern Med 160 2000 1399 1408
5. M.A. Mufson, and R.J. Stanek Bacteremic pneumococcal pneumonia in one American City: a 20-year longitudinal study, 1978-1997 Am J Med 107 1999 34S 43S
6. G.W. Waterer, G.W. Somes, and R.G. Wunderink Monotherapy may be suboptimal for severe bacteremic pneumococcal pneumonia Arch Intern Med 161 2001 1837 1842
7. J.A. Martinez, J.P. Horcajada, and M. Almela Addition of a macrolide to a beta-lactam-based empirical antibiotic regimen is associated with lower in-hospital mortality for patients with bacteremic pneumococcal pneumonia Clin Infect Dis 36 2003 389 395
8. L.A. Mandell, T.J. Marrie, and R.F. Grossman Canadian guidelines for the initial management of community-acquired pneumonia - an evidence-based update by the Canadian Infectious Disease Society and the Canadian Thoracic Society: the Canadian CAP working group Clin Infect Dis 31 2000 383 421
9. M.S. Niederman, L.A. Mandell, and A. Anzueto Guidelines for the management of adults with community acquired pneumonia: diagnosis, assessment of severity, antimicrobial therapy, and prevention Am J Respir Crit Care Med 163 2001 1730 1754
10. J. Hedlund, A. Ortqvist, and T. Ahlqvist Swedish Infectious Diseases Society Pneumonia Study Group: management of patients with community-acquired pneumonia treated in hospital in Sweden Scand J Infect Dis 34 2002 887 892
11. L.A. Mandell, J.G. Bartlett, and S.F. Dowell Update of practice guidelines for the management of community-acquired pneumonia in immunocompetent adults Clin Infect Dis 37 2003 1404 1433
12. T.J. Marrie, H. Durant, and L. Yates Community-acquired pneumonia requiring hospitalization: 5-year prospective study Rev Infect Dis 11 1989 586 599
13. G.D. Fang, M. Fine, and J. Orloff New and emerging etiologies for community-acquired pneumonia with implications for therapy: a prospective multi-center study of 359 cases Medicine (Baltimore) 69 1990 307 316
14. D. Lieberman, F. Schlaeffer, and I. Boldur Multiple pathogens in adult patients admitted with community-acquired pneumonia: a one year prospective study of 346 consecutive patients Thorax 5 1996 179 184
15. B.J. Marston, J.F. Plouffe, and T.M. File Incidence of community-acquired pneumonia requiring hospitalization Arch Intern Med 157 1997 1709 1718
16. C. Jokinen, L. Heiskanen, and H. Juvonen Microbial etiology of community-acquired pneumonia in the adult population of 4 municipalities in eastern Finland Clin Infect Dis 32 2001 1141 1154
17. M. Woodhead Community-acquired pneumonia in Europe: causative pathogens and resistance patterns Eur Respir J Suppl 36 2002 20s 27s
18. T.J. Grayston, C.C. Kuo, S.P. Wang, and J. Altman A new Chlamydia psittaci strain, TWAR, isolated in acute respiratory tract infections N Engl J Med 315 1986 161 168
19. S.F. Dowell, L.J. Anderson, and H.E. Gary Respiratory syncytial virus (RSV) may be an important cause of community-acquired lower respiratory infection among hospitalized adults J Infect Dis 174 1996 456 462
20. T.M. File, J.S. Tan, and J.F. Plouffe The role of atypical pathogens: Mycoplasma pneumoniae, Chlamydia pneumoniae and Legionella pneumonia in respiratory infection Infect Dis Clin North Am 12 1998 569 592
21. T.M. File, J.F. Plouffe, R.F. Breiman, and S.K. Skelton Clinical characteristics of C. pneumoniae infection as the sole cause of community-acquired pneumonia Clin Infect Dis 29 1999 426 428
22. A. Marx, G.E. Howard Jr., B.J. Marston, and L.J. Anderson Parainfluenza virus infection among adults hospitalized for lower respiratory tract infection Clin Infec Dis 29 1999 134 140
23. J.F. Plouffe Importance of atypical pathogens of community-acquired pneumonia Clin Infect Dis 31 Suppl 2 2000 S35 S39
24. J.A. McCullers, and K.C. Bartmess Role of neuraminidase in lethal synergism between influenza virus and Streptococcus pneumoniae J Infect Dis 187 2003 1000 1009
25. N. Bodasing, and D. Kennedy Moraxella catarrhalis bacteraemia associated with Mycoplasma pneumoniae infection and pneumonia Scand J Infect Dis 34 2002 851 852
26. M.J. Tan, J.S. Tan, and T.M. File Jr. Legionnaires disease with bacteremic coinfection Clin Infect Dis 35 2002 533 539
27. J.F. Plouffe, R.F. Breiman, and R.R. Facklam CBPIS study group: Bacteremia with Streptococcus pneumoniae: implications for therapy and prevention JAMA 275 1996 194 198
28. C. Watanakunakorn, and T.A. Bailey Adult bacteremic pneumococcal pneumonia in a community teaching hospital, 1992-1996: a detailed analysis of 108 cases Arch Intern Med 157 1997 1965 1971
29. J.E. Sisk, A.J. Moskowitz, and W. Whang Cost-effectiveness of vaccination against pneumococcal bacteremia among elderly people JAMA 278 1997 1333 1339
30. M.J. Fine, M.A. Smith, and C.A. Carson Prognosis and outcomes of patients with community-acquired pneumonia JAMA 275 1996 134 141
31. T.P. Meehan, M.J. Fine, and H.M. Krumholz Quality of care, process and outcomes in elderly patients with pneumonia JAMA 278 1997 2080 2084
32. P.P. Gleason, T.P. Meehan, and J.M. Fine Association between antimicrobial therapy and medical outcomes for hospitalized elderly patients with pneumonia Arch Intern Med 159 1999 2562 2572
33. G.W. Waterer, S.G. Jennings, and R.G. Wunderink The impact of blood cultures on antibiotic therapy in pneumococcal pneumonia Chest 116 1999 1278 1281
34. C.S. Bryan Blood cultures for community-acquired pneumonia: no place to skimp! Chest 116 1999 1153 1155
35. D.M. Musher, I. Alexandraki, and E.A. Graviss Bacteremic and nonbacteremic pneumococcal pneumonia: a prospective study Medicine (Baltimore) 79 2000 210 221
36. D.R. Murdoch, R.T. Laing, and G.D. Mills Evaluation of a rapid immunochromatographic test for detection of Streptococcus pneumoniae antigen in urine samples from adults with community-acquired pneumonia J Clin Microbiol 39 2001 3495 3498
37. M.D. Smith, P. Derrington, and R. Evans Rapid diagnosis of bacteremic pneumococcal infections in adults by using the Binax NOW Streptococcus pneumoniae urinary antigen test: a prospective, controlled clinical evaluation J Clin Microbiol 41 2003 2810 2813
38. J. Dominguez, S. Blanco, and C. Rodrigo Usefulness of urinary antigen detection by an immunochromatographic test for diagnosis of pneumococcal pneumonia in children J Clin Microbiol 41 2000 2161 2163
39. F. Gutierrez, M. Masia, and J.C. Rodriguez Evaluation of the immunochromatographic Binax NOW assay for detection of Streptococcus pneumoniae urinary antigen in a prospective study of community-acquired pneumonia in Spain Clin Infect Dis 36 2003 286 292
40. A. Ortqvist, M. Kalin, I. Julander, and M.A. Mufson Deaths in bacteremic pneumococcal pneumonia: a comparison of two populations - Huntington, WVa, and Stockholm, Sweden Chest 103 1993 710 716
41. T.J. Marrie Bacteremic pneumococcal pneumonia mortality rate: is it really different in Sweden? Chest 103 1993 658 660
42. E. Lin, R.J. Stanek, and M.A. Mufson Lack of synergy of erythromycin combined with penicillin or cefotaxime against Streptococcus pneumoniae in vitro Antimicrob Agents Chemother 47 2003 1151 1153
43. M.H. Lepper, and H.F. Dowling Treatment of pneumococcal meningitis with penicillin compared with penicillin and aureomycin; studies including observations on an apparent antagonism between penicillin and aureomycin Arch Intern Med 88 1951 489 494
44. M. Lujan, M. Gallego, and D. Fontanals Prospective observational study of bacteremic pneumococcal pneumonia: effect of discordant therapy on mortality Crit Care Med 32 2004 625 631
45. C. McNally, B.A. Hackman, B. Fields, and J.F. Plouffe Potential importance of Legionella species in community acquired pneumonia CAP Diag Microbiol Infect Dis 38 2000 79 82
46. R.R. Muder, and V.L. Yu Infection due to Legionella species other than L. pneuophila Clin Infect Dis 35 2002 990 998
47. A.A. Adelke, B.S. Fieds, and R.F. Benson Legionella drozanskii sp nov, Legionella rowbothamii sp nov and Legionella fallonii sp nov: three new unusual Legionella species Int J Syst Evol Microbial 51 2001 1151 1160
48. T.J. Marrie, D. Raoult, and B. La Scola Legionella-like and other amoebal pathogens as agents of community-acquired pneumonia Emerg Infect Dis 7 2001 1026 1029
49. R.C. Bone, C.J. Fisher, and T.P. Clemmer and the Methylprednisolone Severe Sepsis Study Group: a controlled clinical trial of high-dose methylprednisolone in the treatment of severe sepsis and septic shock N Engl J Med 317 1987 653 658
50. R.L. Greenman, R. Schein, and M.A. Martin A controlled clinical trial of E5 murine monoclonal IgM antibody to endotoxin in the treatment of gram-negative sepsis JAMA 266 1991 1097 1125
51. E. Abraham, R. Wunderink, and H. Silverman Efficacy and safety of monoclonal antibody to human tumor necrosis factor in patients with sepsis syndrome: a randomized, controlled, double-blind, multicenter clinical trial JAMA 273 1995 934 941
52. R.C. Bone, R.A. Balk, and A.M. Fein A second large controlled clinical study of E5, a monoclonal antibody to endotoxin: results of a prospective, multicenter, randomized, controlled trial Crit Care Med 23 1995 994 1005
53. C.M. Odio, I. Faingezicht, and M. Paris The beneficial effects of early dexamethasone administration in infants and children with bacterial meningitis N Engl J Med 324 1991 1525 1531
54. J. de Gans, and D. vad de Beek European dexamethasone in adulthood bacterial meningitis study investigators: dexamethasone in adults with bacterial meningitis N Engl J Med 347 2002 1549 1556
55. A.W. Rijneveld, S. Florquin, and T. Hartung Anti-tumor necrosis factor antibody impairs the therapeutic effect of ceftriaxone in murine pneumococcal pneumonia J Infect Dis 188 2003 282 285
56. S. Harbarth, J. Garbino, and D. Pittet Is anti-tumor necrosis factor therapy associated with increased mortality in patients with severe sepsis caused by pneumonia? J Infect Dis 189 2004 1743
57. S. Knapp, L. Hareng, and A. Rijneveld Activation of neutrophils and inhibition of the proinflammatory cytokine response by endogenous granulocyte colony stimulating factor in murine pneumococcal pneumonia J Infect Dis 189 2004 1506 1514
58. G.D. Campbell Jr., and R. Silberman Drug-resistant Streptococcus pneumoniae Clin Infect Dis 26 1998 1188 1195
59. J.A. Karlowsky, C. Thornsberry, and M.E. Jones TRUST Surveillance Program. Factors associated with relative rates of antimicrobial resistance among Streptococcus pneumoniae in the United States: results from the TRUST Surveillance Program (1998-2002) Clin Infect Dis 36 2003 963 970
60. R.N. Jones, D.J. Biedenbach, and M.L. Beach Influence of patient age on the susceptibility patterns of Streptococcus pneumoniae isolates in North America (2000-2001): report from the SENTRY Antimicrobial Surveillance Program Diagn Microbiol Infect Dis 46 2003 77 80
61. V.L. Yu, C.C. Chiou, and C. Feldman International Pneumococcal Study Group: an international prospective study of pneumococcal bacteremia. Correlation with in vitro resistance, antibiotics administered, and clinical outcome Clin Infect Dis 37 2003 230 237
62. F. Sanchez, J. Mensa, and J.A. Martinez Is azithromycin the first-choice macrolide for treatment of community-acquired pneumonia? Clin Infect Dis 36 2003 1239 1245
63. S.F. Dowell The best treatment of pneumonia: new clues, but no definitive answers Arch Intern Med 159 1999 2511 2512
64. T.M. File, and L.A. Mandell What is optimal therapy for bacteremic pneumococcal pneumonia? Clin Infect Dis 36 2003 396 398
65. F.J. Martinez Monotherapy versus dual therapy for community-acquired pneumonia in hospitalized patients Clin Infect Dis 38 Suppl 4 2004 S328 S340
66. C. Darras-Joly, J.P. Bedos, and C. Sauve Synergy between amoxicillin and gentamicin in combination against a highly penicillin-resistant and -tolerant strain of Streptococcus pneumoniae in a mouse neumonia model Antimicrob Agents Chemother 40 1996 2147 2151
67. L. De Hennezel, F. Ramisse, and P. Binder Effective combination therapy for invasive pneumococcal pneumonia with ampicillin and intravenous immunoglobulins in a mouse model Antimicrob Agents Chemother 45 2001 316 318
68. A.W. Rijneveld, S. Florquin, and J. Branger TNF-alpha compensates for the impaired host defense of IL-1 type I receptor-deficient mice during pneumococcal pneumonia J Immunol 167 2001 5240 5246
69. T. van der Poll, C.V. Keogh, and X. Guirao Interleukin-6 gene-deficient mice show impaired defense against pneumococcal pneumonia J Infect Dis 176 1997 439 444
70. F.N. Lauw, J. Branger, and S. Florquin IL-18 improves the early antimicrobial host response to pneumococcal pneumonia J Immunol 168 2002 372 378
71. S. Knapp, J.C. Leemans, and S. Florquin Alveolar macrophages have a protective antiinflammatory role during murine pneumococcal pneumonia Am J Respir Crit Care Med 167 2003 171 179
72. A.W. Rijneveld, S. Weijer, and S. Florquin Improved host defense against pneumococcal pneumonia in platelet-activating factor receptor-deficient mice J Infect Dis 189 2004 711 716
73. C.E. Blue, G.K. Paterson, and A.R. Kerr ZmpB, a novel virulence factor of Streptococcus pneumoniae that induces tumor necrosis factor alpha production in the respiratory tract Infect Immun 71 2003 4925 4935